New Key Statistics Module, Z-Score and F-Score
NAS:CLDX Key Ratios
| Market Cap $ M | 3,173.38 |
| Enterprise Value $ M | 2,460.70 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.44 |
| Price/Sales | 20,205.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -4.35 |
| Beneish M-Score | 74.25 |
| 10-y EBITDA Growth Rate % | 18.40 |
| 5-y EBITDA Growth Rate % | -23.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.55 |
| EV-to-EBITDA | -7.63 |
| PEG | -- |
| Shares Outstanding M | 78.53 |
| Net Margin (%) | -190,220.89 |
| Operating Margin % | -206,220.25 |
| Pre-tax Margin (%) | -190,220.89 |
| Quick Ratio | 11.82 |
| Current Ratio | 11.82 |
| ROA % (ttm) | -46.71 |
| ROE % (ttm) | -50.91 |
| ROIC % (ttm) | -628.81 |
| Dividend Yield % | -- |
| Altman Z-Score | 24.32 |
CLDX Number of Guru Trades
CLDX Volume of Guru Trades
Gurus Latest Trades with NAS:CLDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CLDX is held by these investors
Total 1
Celldex Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CLDX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers